(Philadelphia, PA) - Yassine Amrani, PhD, has been appointed Research Assistant Professor in the Department of Medicine, Division of Pulmonary, Allergy and Critical Care, at the University of Pennsylvania School of Medicine.

Dr. Amrani holds a Masters of Science degree in Cellular Biology from the University of Constantine in Algeria and earned a Masters of Science degree in Pharmacology, as well as a Doctor of Philosophy degree in Pulmonary Pharmacology, from the University of Strasbourg I in France.

His primary research focuses on understanding the cellular and molecular mechanisms that regulate bronchial hyper-responsiveness, a defining characteristic of allergic asthma. Dr. Amrani was amongst the first in the field to suggest that abnormalities in airway smooth muscle, an important tissue in regulating the bronchomotor tone in healthy conditions, may play an important role in the development of the non-specific bronchial hyper-responsiveness in asthma to pharmacological agents. These findings showed that targeting airway smooth muscle may serve as a new potential therapeutic approach for the treatment of chronic lung diseases. Dr. Amrani's research is supported by the Parker B. Francis Fellowship for Pulmonary research and grants from the American Lung Association and the National Institutes of Health. His research has been published in the European Journal of Pharmacology, the British Journal of Pharmacology, the American Journal of Respiratory Cell and Molecular Biology, the Faseb Journal, the Journal of Clinical Investigation and the Journal of Immunology, among others.

Dr. Amrani is a member of the American Society for Pharmacology and Experimental Therapeutics and the American Association of Immunologists. He is an ad-hoc reviewer for many journals including the American Journal of Physiology and the Journal of Immunology. Among his many accolades, he has received Fellowship Awards from the Association Claude Bernard, the Fondation pour la Recherche Médicale, and the Association Francaise pour la Recherché Thérapeutique, all in Paris, France.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.

Share This Page: